X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility

Content Team by Content Team
29th January 2022
in Packaging & Logistic, Press Statements
Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility

Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.

The investment at Heerenveen comes in response to the increasing demand from sponsors and manufacturers of gene therapies for dedicated, specialist packaging capacity. The Heerenveen site complements similar capabilities available at the company’s Bethlehem, PA facility, as it looks to offer support for clients in both the US and European markets.

The new secondary packaging area was designed to offer the optimal environment to address the complexities of gene therapies specifically, labelling and packaging vials and injectables at low volumes and low temperatures, for distribution in cold and ultra-cold supply chains.

The Heerenveen facility includes air handling systems, controlled temperatures and humidity, a walk-in 2-8oC packaging suite, as well as freezer banks with a range of temperatures to -80oC.  The site also provides key operational efficiencies through its electronic batch record and a standardized Quality management system.

Services and support offered at Heerenveen includes:

  • Storage, including freezer banks for multi-temperature ranges from -20 to -80
  • Primary and secondary labelling of vials, pre-filled syringes
  • Walk-in 2-8oC packaging suite
  • Custom label generation for randomised clinical trials
  • Secondary packaging & kitting
  • Electronic batch records
  • Serialization and aggregation
  • QP services, including market release
  • Distribution

On these new capabilities, Vesna Bondzulic, site manager at Sharp Heerenveen said:

“We recognise the enormous promise of gene therapies, as well as the unique complexities they can present to traditional pharma supply chains. Sharp can offer a blend of commercial packaging and small-scale clinical supply expertise to address these challenges for our clients, as well as QP market release for the European market. Everyone at Sharp is excited to collaborate with our clients as we help them bring life-changing and potentially curative therapies to the patients who need them.”

Heerenveen received Investigational Medicinal Product (IMP) and Wholesale Distribution Authorisation (WDA) licensing approvals in 2018, co-locating commercial packaging and clinical services at the facility.

About Sharp

Sharp is a global leader in clinical supply chain services and pharmaceutical packaging. For more than 65 years, we’ve provided solutions to pharma and biotech clients from phase I trials through to commercial launch and lifecycle management. With facilities in the United States, United Kingdom, Belgium and the Netherlands and 30+ clinical depots globally, covering every region of the world, we are engineered to deliver.

Through our partnership with Berkshire Sterile Manufacturing, we offer specialist isolator-based filling of vials, syringes, cartridges and containers, as well as lyophilization and terminal sterilization.

Our full complement of integrated services includes: research and development, clinical manufacturing, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage and distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of the EU and UK.

Previous Post

Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

Next Post

Cryoport and Cell Matters Enter into Strategic Partnership

Related Posts

News

Energy Crises May Impair European Medicine Supply Lines

2nd November 2022
News

Biopharma Sector Emergence of Third-Party Logistics Market

1st November 2022
Press Statements

Final Report ACHEMA 2022

19th September 2022
Empowering the healthcare fraternity through dynamic online courses
Manufacturing

Empowering the healthcare fraternity through dynamic online courses

9th September 2022
Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022
Manufacturing

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

27th August 2022
AstraZeneca's Enhertu wins keenly-anticipated U.S. breast cancer nod
FDA Approvals

AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod

5th August 2022
Next Post
Cryoport and Cell Matters Enter into Strategic Partnership

Cryoport and Cell Matters Enter into Strategic Partnership

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In